Literature DB >> 12536227

Glial involvement in diffuse Lewy body disease.

Seishi Terada1, Hideki Ishizu, Osamu Yokota, Kuniaki Tsuchiya, Hanae Nakashima, Takeshi Ishihara, Daisuke Fujita, Kenji Uéda, Kenji Ikeda, Shigetoshi Kuroda.   

Abstract

Diffuse Lewy body disease (DLBD) is characterized by the presence of Lewy bodies (LB) in the neurons and neurites of cortical, subcortical, and brain stem structures. Recently, alpha-synuclein (alphaS) has been found to be a central constituent of LB. In DLBD, abnormal accumulation of alphaS has been reported in both neurons and glia, but studies on glial lesions in DLBD have been limited. We examined in detail the constituents and distribution of glial lesions in eight patients with DLBD and report the pathogenesis of the glial lesions. alphaS-positive neuronal cytoplasmic inclusions (NI), neuropil threads (NT), and coiled bodies (CB) showed similar immunostaining profiles. Without pretreatment, NI, NT, and CB were detected by all antibodies against alphaS. The immunostaining profile of star-like astrocytes (SLA) was quite different from those of NI, NT, and CB. A few SLA were stained by an antibody against the non-Abeta component portion of alphaS without pretreatment, but formic acid pretreatment dramatically enhanced SLA immunoreactivity. SLA and CB were found in all eight brains with DLBD. SLA were scarce in the brain stem, but there were hundreds of SLA per visual field at x100 magnification in the temporal cortex of most cases, while CB were found diffusely in both the cerebral cortex and brain stem, similar to NI. This suggests that the pathogenesis of SLA is different from those of NI and CB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536227     DOI: 10.1007/s00401-002-0622-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.

Authors:  He-Jin Lee; Ji-Eun Suk; Christina Patrick; Eun-Jin Bae; Ji-Hoon Cho; Sangchul Rho; Daehee Hwang; Eliezer Masliah; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

Review 2.  The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Authors:  J Schapansky; J D Nardozzi; M J LaVoie
Journal:  Neuroscience       Date:  2014-10-02       Impact factor: 3.590

3.  Human beta-synuclein rendered fibrillogenic by designed mutations.

Authors:  Shahin Zibaee; Graham Fraser; Ross Jakes; David Owen; Louise C Serpell; R Anthony Crowther; Michel Goedert
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

Review 4.  Defective autophagy in Parkinson's disease: role of oxidative stress.

Authors:  Elzbieta Janda; Ciro Isidoro; Cristina Carresi; Vincenzo Mollace
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

Review 5.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

6.  Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.

Authors:  Xing-Long Gu; Cai-Xia Long; Lixin Sun; Chengsong Xie; Xian Lin; Huaibin Cai
Journal:  Mol Brain       Date:  2010-04-21       Impact factor: 4.041

7.  CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

Authors:  Lumine Matsumoto; Hiroshi Takuma; Akira Tamaoka; Hiroshi Kurisaki; Hidetoshi Date; Shoji Tsuji; Atsushi Iwata
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

8.  Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.

Authors:  Norihito Uemura; Maiko T Uemura; Angela Lo; Fares Bassil; Bin Zhang; Kelvin C Luk; Virginia M-Y Lee; Ryosuke Takahashi; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2019-10-01       Impact factor: 3.685

9.  Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.

Authors:  Linn Streubel-Gallasch; Veronica Giusti; Michele Sandre; Isabella Tessari; Nicoletta Plotegher; Elena Giusto; Anna Masato; Ludovica Iovino; Ilaria Battisti; Giorgio Arrigoni; Derya Shimshek; Elisa Greggio; Marie-Eve Tremblay; Luigi Bubacco; Anna Erlandsson; Laura Civiero
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

10.  Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.

Authors:  Michela Deleidi; Walter Maetzler
Journal:  Int J Alzheimers Dis       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.